20 17, 10, 12, Hong Kong stock Huaxia Health (HK 1 143) issued an announcement to acquire 84. 1% of Lanzhou Tianke Health Technology Co., Ltd. in cash. This marks that China's first polyurethane condom brand Zhongchuan 00 1 officially opened the road to internationalization and became the first condom in China.
2. Renfu Medicine
In 20 17, Renfu Medicine announced the acquisition of Ansel's Jasper condom business and other gender health businesses, which also means that the company will soon become the second largest condom giant in the world. However, the eyes of the market are sharp. After the announcement of this news, the share price of Renfu Pharmaceutical fell to a limit on the day of resumption of trading, and the decline in the late session narrowed slightly, closing down more than 8%.
3. Wan Defu
20 15 is destined to be an extraordinary year for Jinhua Wan Defu, a manufacturing enterprise located in Jinhua City, Zhejiang Province. After a series of processes such as share reform, it finally went public successfully and became the first adult product in China.
4. North Science and Technology
2065438+On April 20th, 2006, Northstar (836309) was listed in the national share transfer system for small and medium-sized enterprises. This is also the first condom concept company to land in the New Third Board market.
According to the data, the main business of North Technology is the research, development, design and sales of "North" brand condoms and peripheral products. In 20 15, the company realized an operating income of 97.577 million yuan, a year-on-year increase of19.68%; The net profit was 4,968,600 yuan, a year-on-year increase of 2066.57%.
Extended data
From 20 17 to 20 19, the gross profit margin of Renfu medical condoms was 49.78%, 57.07% and 59.45% respectively, which was much higher than its main medical income and drug income, and the income increased year by year, reaching 657 million yuan,18.24 million yuan and 654.38+respectively.
With the aura of "the first condom concept", Renfu Medicine has been "two in and three out" in the field of sexual health products. In 2006 and 2009, Renfu Medicine sold the equity of Wuhan Jasper to Ansel Group twice.
20 17 Renfu Medicine and CITIC Capital acquired the sexual health business segment of Ansel Group for US$ 600 million, and newly established Love Life Group. This time, under the strategic layout of refocusing, Renfu Medicine slimmed down again and sold the assets of sexual health products for the third time.
He Xun. Com- What is the logic of Renfu Medicine selling Carlsberg shares for $200 million, abandoning "condoms" and adding more anesthetic?
He Xun. Com- Si Nuo technology listed the new third board
China securities journal-Renfu Medicine's share price is depressed: it is difficult to catch up with Durex, the boss, by selling low and buying expensive.
Phoenix. Com- Huaxia Health acquired 84. 1% equity of Tianke Health, leading Zhongchuan 00 1 brand to the international market.
China economic herald (a comprehensive economic newspaper publicly issued by the National Development and Reform Commission at home and abroad)-Jinhua Wan Defu New Third Board was successfully listed and entered the adult products market.